Statistics

Total Visits

Views
Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia(legacy) 184
Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia(legacy) 112

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia 1 7 1 0 2 7 1

File Downloads

Views
hdl_83386.pdf(legacy) 114
hdl_83386.pdf 78

Top Country Views

Views
United States 71
Germany 42
China 21
Australia 14
Vietnam 14
Netherlands 8
France 5
Hong Kong SAR China 2
Finland 1
India 1

Top City Views

Views
Ashburn 28
Hanoi 14
Kaleen 13
Beijing 12
Fairfield 12
Rotterdam 8
Cambridge 4
Zhengzhou 3
Boardman 2
Central 2